Clinical Trial Update: Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating the combination of zoledronic acid and interleukin-2 in children with refractory neuroblastoma. The trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neuroblastoma | Phase 1 | Status: TERMINATED